Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Beale

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|March 10, 2005
Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patientsD Goldstein, P Mitchell, M Michael, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomideP Beale, I Judson, S Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trialS B Park, J B Kwok, R Asher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continuous infusion to patients with refractory solid malignanciesCharlotte Rees, P Beale, Jose Manuel Trigo, et al.
Internal Medicine Journal|October 18, 2016
Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centresE Ip, A M J Pokorny, S Della-Fiorentina, et al.
British Journal of Cancer|April 3, 2003
A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)P Beale, I Judson, A O'Donnell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trialB Oh, P Butow, B Mullan, et al.
Internal Medicine Journal|April 9, 2015
Doctor-to-doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctorsE B Moth, J Parry, M R Stockler, et al.
Gynecologic Oncology|November 3, 2006
Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01A V Tinker, V Gebski, B Fitzharris, et al.
British Journal of Cancer|November 20, 1998
Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694)I Judson, T Maughan, P Beale, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|March 10, 2005
Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patientsD Goldstein, P Mitchell, M Michael, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomideP Beale, I Judson, S Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trialS B Park, J B Kwok, R Asher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continuous infusion to patients with refractory solid malignanciesCharlotte Rees, P Beale, Jose Manuel Trigo, et al.
Internal Medicine Journal|October 18, 2016
Use of palliative chemotherapy in patients aged 80 years and over with incurable cancer: experience at three Sydney cancer centresE Ip, A M J Pokorny, S Della-Fiorentina, et al.
British Journal of Cancer|April 3, 2003
A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)P Beale, I Judson, A O'Donnell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trialB Oh, P Butow, B Mullan, et al.
Internal Medicine Journal|April 9, 2015
Doctor-to-doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctorsE B Moth, J Parry, M R Stockler, et al.
Gynecologic Oncology|November 3, 2006
Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01A V Tinker, V Gebski, B Fitzharris, et al.
British Journal of Cancer|November 20, 1998
Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694)I Judson, T Maughan, P Beale, et al.
Pageof 7